Request for Covid-19 Impact Assessment of this Report
The United States Insulin Syringes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Insulin Syringes market, reaching US$ million by the year 2028. As for the Europe Insulin Syringes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Insulin Syringes players cover Novo Nordisk, Sanofi, Eli Lilly and Company, and Biocon Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Insulin Syringes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
3/10 CC Syringe
1/2 CC Syringe
1 CC Syringe
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Homecare
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novo Nordisk
Sanofi
Eli Lilly and Company
Biocon Ltd
Ypsomed AG
Wockhardt Ltd
Medtronic Plc
Abbott Laboratories
Animas Corporation
F. Hoffmann-La Roche
BD
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Insulin Syringes Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Insulin Syringes by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Insulin Syringes by Country/Region, 2017, 2022 & 2028
2.2 Insulin Syringes Segment by Type
2.2.1 3/10 CC Syringe
2.2.2 1/2 CC Syringe
2.2.3 1 CC Syringe
2.2.4 Others
2.3 Insulin Syringes Sales by Type
2.3.1 Global Insulin Syringes Sales Market Share by Type (2017-2022)
2.3.2 Global Insulin Syringes Revenue and Market Share by Type (2017-2022)
2.3.3 Global Insulin Syringes Sale Price by Type (2017-2022)
2.4 Insulin Syringes Segment by Application
2.4.1 Hospital
2.4.2 Homecare
2.4.3 Others
2.5 Insulin Syringes Sales by Application
2.5.1 Global Insulin Syringes Sale Market Share by Application (2017-2022)
2.5.2 Global Insulin Syringes Revenue and Market Share by Application (2017-2022)
2.5.3 Global Insulin Syringes Sale Price by Application (2017-2022)
3 Global Insulin Syringes by Company
3.1 Global Insulin Syringes Breakdown Data by Company
3.1.1 Global Insulin Syringes Annual Sales by Company (2020-2022)
3.1.2 Global Insulin Syringes Sales Market Share by Company (2020-2022)
3.2 Global Insulin Syringes Annual Revenue by Company (2020-2022)
3.2.1 Global Insulin Syringes Revenue by Company (2020-2022)
3.2.2 Global Insulin Syringes Revenue Market Share by Company (2020-2022)
3.3 Global Insulin Syringes Sale Price by Company
3.4 Key Manufacturers Insulin Syringes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Insulin Syringes Product Location Distribution
3.4.2 Players Insulin Syringes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Insulin Syringes by Geographic Region
4.1 World Historic Insulin Syringes Market Size by Geographic Region (2017-2022)
4.1.1 Global Insulin Syringes Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Insulin Syringes Annual Revenue by Geographic Region
4.2 World Historic Insulin Syringes Market Size by Country/Region (2017-2022)
4.2.1 Global Insulin Syringes Annual Sales by Country/Region (2017-2022)
4.2.2 Global Insulin Syringes Annual Revenue by Country/Region
4.3 Americas Insulin Syringes Sales Growth
4.4 APAC Insulin Syringes Sales Growth
4.5 Europe Insulin Syringes Sales Growth
4.6 Middle East & Africa Insulin Syringes Sales Growth
5 Americas
5.1 Americas Insulin Syringes Sales by Country
5.1.1 Americas Insulin Syringes Sales by Country (2017-2022)
5.1.2 Americas Insulin Syringes Revenue by Country (2017-2022)
5.2 Americas Insulin Syringes Sales by Type
5.3 Americas Insulin Syringes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insulin Syringes Sales by Region
6.1.1 APAC Insulin Syringes Sales by Region (2017-2022)
6.1.2 APAC Insulin Syringes Revenue by Region (2017-2022)
6.2 APAC Insulin Syringes Sales by Type
6.3 APAC Insulin Syringes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Insulin Syringes by Country
7.1.1 Europe Insulin Syringes Sales by Country (2017-2022)
7.1.2 Europe Insulin Syringes Revenue by Country (2017-2022)
7.2 Europe Insulin Syringes Sales by Type
7.3 Europe Insulin Syringes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Insulin Syringes by Country
8.1.1 Middle East & Africa Insulin Syringes Sales by Country (2017-2022)
8.1.2 Middle East & Africa Insulin Syringes Revenue by Country (2017-2022)
8.2 Middle East & Africa Insulin Syringes Sales by Type
8.3 Middle East & Africa Insulin Syringes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Insulin Syringes
10.3 Manufacturing Process Analysis of Insulin Syringes
10.4 Industry Chain Structure of Insulin Syringes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Insulin Syringes Distributors
11.3 Insulin Syringes Customer
12 World Forecast Review for Insulin Syringes by Geographic Region
12.1 Global Insulin Syringes Market Size Forecast by Region
12.1.1 Global Insulin Syringes Forecast by Region (2023-2028)
12.1.2 Global Insulin Syringes Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Insulin Syringes Forecast by Type
12.7 Global Insulin Syringes Forecast by Application
13 Key Players Analysis
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Insulin Syringes Product Offered
13.1.3 Novo Nordisk Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Insulin Syringes Product Offered
13.2.3 Sanofi Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Information
13.3.2 Eli Lilly and Company Insulin Syringes Product Offered
13.3.3 Eli Lilly and Company Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Eli Lilly and Company Main Business Overview
13.3.5 Eli Lilly and Company Latest Developments
13.4 Biocon Ltd
13.4.1 Biocon Ltd Company Information
13.4.2 Biocon Ltd Insulin Syringes Product Offered
13.4.3 Biocon Ltd Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biocon Ltd Main Business Overview
13.4.5 Biocon Ltd Latest Developments
13.5 Ypsomed AG
13.5.1 Ypsomed AG Company Information
13.5.2 Ypsomed AG Insulin Syringes Product Offered
13.5.3 Ypsomed AG Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Ypsomed AG Main Business Overview
13.5.5 Ypsomed AG Latest Developments
13.6 Wockhardt Ltd
13.6.1 Wockhardt Ltd Company Information
13.6.2 Wockhardt Ltd Insulin Syringes Product Offered
13.6.3 Wockhardt Ltd Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Wockhardt Ltd Main Business Overview
13.6.5 Wockhardt Ltd Latest Developments
13.7 Medtronic Plc
13.7.1 Medtronic Plc Company Information
13.7.2 Medtronic Plc Insulin Syringes Product Offered
13.7.3 Medtronic Plc Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Medtronic Plc Main Business Overview
13.7.5 Medtronic Plc Latest Developments
13.8 Abbott Laboratories
13.8.1 Abbott Laboratories Company Information
13.8.2 Abbott Laboratories Insulin Syringes Product Offered
13.8.3 Abbott Laboratories Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Abbott Laboratories Main Business Overview
13.8.5 Abbott Laboratories Latest Developments
13.9 Animas Corporation
13.9.1 Animas Corporation Company Information
13.9.2 Animas Corporation Insulin Syringes Product Offered
13.9.3 Animas Corporation Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Animas Corporation Main Business Overview
13.9.5 Animas Corporation Latest Developments
13.10 F. Hoffmann-La Roche
13.10.1 F. Hoffmann-La Roche Company Information
13.10.2 F. Hoffmann-La Roche Insulin Syringes Product Offered
13.10.3 F. Hoffmann-La Roche Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 F. Hoffmann-La Roche Main Business Overview
13.10.5 F. Hoffmann-La Roche Latest Developments
13.11 BD
13.11.1 BD Company Information
13.11.2 BD Insulin Syringes Product Offered
13.11.3 BD Insulin Syringes Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 BD Main Business Overview
13.11.5 BD Latest Developments
14 Research Findings and Conclusion
Table 1. Insulin Syringes Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Insulin Syringes Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 3/10 CC Syringe
Table 4. Major Players of 1/2 CC Syringe
Table 5. Major Players of 1 CC Syringe
Table 6. Major Players of Others
Table 7. Global Insulin Syringes Sales by Type (2017-2022) & (K Units)
Table 8. Global Insulin Syringes Sales Market Share by Type (2017-2022)
Table 9. Global Insulin Syringes Revenue by Type (2017-2022) & ($ million)
Table 10. Global Insulin Syringes Revenue Market Share by Type (2017-2022)
Table 11. Global Insulin Syringes Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Insulin Syringes Sales by Application (2017-2022) & (K Units)
Table 13. Global Insulin Syringes Sales Market Share by Application (2017-2022)
Table 14. Global Insulin Syringes Revenue by Application (2017-2022)
Table 15. Global Insulin Syringes Revenue Market Share by Application (2017-2022)
Table 16. Global Insulin Syringes Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Insulin Syringes Sales by Company (2020-2022) & (K Units)
Table 18. Global Insulin Syringes Sales Market Share by Company (2020-2022)
Table 19. Global Insulin Syringes Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Insulin Syringes Revenue Market Share by Company (2020-2022)
Table 21. Global Insulin Syringes Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Insulin Syringes Producing Area Distribution and Sales Area
Table 23. Players Insulin Syringes Products Offered
Table 24. Insulin Syringes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Insulin Syringes Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Insulin Syringes Sales Market Share Geographic Region (2017-2022)
Table 29. Global Insulin Syringes Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Insulin Syringes Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Insulin Syringes Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Insulin Syringes Sales Market Share by Country/Region (2017-2022)
Table 33. Global Insulin Syringes Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Insulin Syringes Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Insulin Syringes Sales by Country (2017-2022) & (K Units)
Table 36. Americas Insulin Syringes Sales Market Share by Country (2017-2022)
Table 37. Americas Insulin Syringes Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Insulin Syringes Revenue Market Share by Country (2017-2022)
Table 39. Americas Insulin Syringes Sales by Type (2017-2022) & (K Units)
Table 40. Americas Insulin Syringes Sales Market Share by Type (2017-2022)
Table 41. Americas Insulin Syringes Sales by Application (2017-2022) & (K Units)
Table 42. Americas Insulin Syringes Sales Market Share by Application (2017-2022)
Table 43. APAC Insulin Syringes Sales by Region (2017-2022) & (K Units)
Table 44. APAC Insulin Syringes Sales Market Share by Region (2017-2022)
Table 45. APAC Insulin Syringes Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Insulin Syringes Revenue Market Share by Region (2017-2022)
Table 47. APAC Insulin Syringes Sales by Type (2017-2022) & (K Units)
Table 48. APAC Insulin Syringes Sales Market Share by Type (2017-2022)
Table 49. APAC Insulin Syringes Sales by Application (2017-2022) & (K Units)
Table 50. APAC Insulin Syringes Sales Market Share by Application (2017-2022)
Table 51. Europe Insulin Syringes Sales by Country (2017-2022) & (K Units)
Table 52. Europe Insulin Syringes Sales Market Share by Country (2017-2022)
Table 53. Europe Insulin Syringes Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Insulin Syringes Revenue Market Share by Country (2017-2022)
Table 55. Europe Insulin Syringes Sales by Type (2017-2022) & (K Units)
Table 56. Europe Insulin Syringes Sales Market Share by Type (2017-2022)
Table 57. Europe Insulin Syringes Sales by Application (2017-2022) & (K Units)
Table 58. Europe Insulin Syringes Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Insulin Syringes Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Insulin Syringes Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Insulin Syringes Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Insulin Syringes Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Insulin Syringes Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Insulin Syringes Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Insulin Syringes Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Insulin Syringes Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Insulin Syringes
Table 68. Key Market Challenges & Risks of Insulin Syringes
Table 69. Key Industry Trends of Insulin Syringes
Table 70. Insulin Syringes Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Insulin Syringes Distributors List
Table 73. Insulin Syringes Customer List
Table 74. Global Insulin Syringes Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Insulin Syringes Sales Market Forecast by Region
Table 76. Global Insulin Syringes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Insulin Syringes Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Insulin Syringes Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Insulin Syringes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Insulin Syringes Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Insulin Syringes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Insulin Syringes Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Insulin Syringes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Insulin Syringes Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Insulin Syringes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Insulin Syringes Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Insulin Syringes Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Insulin Syringes Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Insulin Syringes Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Insulin Syringes Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Insulin Syringes Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Insulin Syringes Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Insulin Syringes Revenue Market Share Forecast by Application (2023-2028)
Table 94. Novo Nordisk Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 95. Novo Nordisk Insulin Syringes Product Offered
Table 96. Novo Nordisk Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Novo Nordisk Main Business
Table 98. Novo Nordisk Latest Developments
Table 99. Sanofi Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Insulin Syringes Product Offered
Table 101. Sanofi Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Eli Lilly and Company Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 105. Eli Lilly and Company Insulin Syringes Product Offered
Table 106. Eli Lilly and Company Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Eli Lilly and Company Main Business
Table 108. Eli Lilly and Company Latest Developments
Table 109. Biocon Ltd Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 110. Biocon Ltd Insulin Syringes Product Offered
Table 111. Biocon Ltd Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Biocon Ltd Main Business
Table 113. Biocon Ltd Latest Developments
Table 114. Ypsomed AG Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 115. Ypsomed AG Insulin Syringes Product Offered
Table 116. Ypsomed AG Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Ypsomed AG Main Business
Table 118. Ypsomed AG Latest Developments
Table 119. Wockhardt Ltd Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 120. Wockhardt Ltd Insulin Syringes Product Offered
Table 121. Wockhardt Ltd Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Wockhardt Ltd Main Business
Table 123. Wockhardt Ltd Latest Developments
Table 124. Medtronic Plc Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 125. Medtronic Plc Insulin Syringes Product Offered
Table 126. Medtronic Plc Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Medtronic Plc Main Business
Table 128. Medtronic Plc Latest Developments
Table 129. Abbott Laboratories Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 130. Abbott Laboratories Insulin Syringes Product Offered
Table 131. Abbott Laboratories Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Abbott Laboratories Main Business
Table 133. Abbott Laboratories Latest Developments
Table 134. Animas Corporation Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 135. Animas Corporation Insulin Syringes Product Offered
Table 136. Animas Corporation Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Animas Corporation Main Business
Table 138. Animas Corporation Latest Developments
Table 139. F. Hoffmann-La Roche Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 140. F. Hoffmann-La Roche Insulin Syringes Product Offered
Table 141. F. Hoffmann-La Roche Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. F. Hoffmann-La Roche Main Business
Table 143. F. Hoffmann-La Roche Latest Developments
Table 144. BD Basic Information, Insulin Syringes Manufacturing Base, Sales Area and Its Competitors
Table 145. BD Insulin Syringes Product Offered
Table 146. BD Insulin Syringes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. BD Main Business
Table 148. BD Latest Developments
List of Figures
Figure 1. Picture of Insulin Syringes
Figure 2. Insulin Syringes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Insulin Syringes Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Insulin Syringes Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Insulin Syringes Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 3/10 CC Syringe
Figure 10. Product Picture of 1/2 CC Syringe
Figure 11. Product Picture of 1 CC Syringe
Figure 12. Product Picture of Others
Figure 13. Global Insulin Syringes Sales Market Share by Type in 2021
Figure 14. Global Insulin Syringes Revenue Market Share by Type (2017-2022)
Figure 15. Insulin Syringes Consumed in Hospital
Figure 16. Global Insulin Syringes Market: Hospital (2017-2022) & (K Units)
Figure 17. Insulin Syringes Consumed in Homecare
Figure 18. Global Insulin Syringes Market: Homecare (2017-2022) & (K Units)
Figure 19. Insulin Syringes Consumed in Others
Figure 20. Global Insulin Syringes Market: Others (2017-2022) & (K Units)
Figure 21. Global Insulin Syringes Sales Market Share by Application (2017-2022)
Figure 22. Global Insulin Syringes Revenue Market Share by Application in 2021
Figure 23. Insulin Syringes Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Insulin Syringes Revenue Market Share by Company in 2021
Figure 25. Global Insulin Syringes Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Insulin Syringes Revenue Market Share by Geographic Region in 2021
Figure 27. Global Insulin Syringes Sales Market Share by Region (2017-2022)
Figure 28. Global Insulin Syringes Revenue Market Share by Country/Region in 2021
Figure 29. Americas Insulin Syringes Sales 2017-2022 (K Units)
Figure 30. Americas Insulin Syringes Revenue 2017-2022 ($ Millions)
Figure 31. APAC Insulin Syringes Sales 2017-2022 (K Units)
Figure 32. APAC Insulin Syringes Revenue 2017-2022 ($ Millions)
Figure 33. Europe Insulin Syringes Sales 2017-2022 (K Units)
Figure 34. Europe Insulin Syringes Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Insulin Syringes Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Insulin Syringes Revenue 2017-2022 ($ Millions)
Figure 37. Americas Insulin Syringes Sales Market Share by Country in 2021
Figure 38. Americas Insulin Syringes Revenue Market Share by Country in 2021
Figure 39. United States Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Insulin Syringes Sales Market Share by Region in 2021
Figure 44. APAC Insulin Syringes Revenue Market Share by Regions in 2021
Figure 45. China Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Insulin Syringes Sales Market Share by Country in 2021
Figure 52. Europe Insulin Syringes Revenue Market Share by Country in 2021
Figure 53. Germany Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Insulin Syringes Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Insulin Syringes Revenue Market Share by Country in 2021
Figure 60. Egypt Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Insulin Syringes Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Insulin Syringes in 2021
Figure 66. Manufacturing Process Analysis of Insulin Syringes
Figure 67. Industry Chain Structure of Insulin Syringes
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...